Muscle Injury Clinical Trial
— MTURROfficial title:
Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) With the Use of Biologic Scaffolds for Patients Suffering From Severe Skeletal Muscle Injury (Coordinating Center Protocol)
The objective of the study is to assess mechanical strength and function in subjects undergoing Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) with the use of biologic scaffolds for the restoration of both mechanical strength and function in these subjects. This study will formally evaluate healing and return of function after an extracellular matrix device implantation in 40 male and female subjects participating at 4-5 military sites who suffer from injury with loss of skeletal muscle tissue. The University of Pittsburgh under the Department of Plastic and Reconstructive Surgery is the Coordinating Center for this multi-site study.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | November 2014 |
Est. primary completion date | November 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Patients with the following characteristics will be eligible to participate in the study: - Age: 18 to 70 years of age and able to provide informed consent - Civilian, and current or former military personnel are eligible to participate - Have suffered injury resulting in a structural deficit of a minimum of 20% of the muscle group mass and a functional deficit of a minimum of 25% when compared to the contralateral limb; or if bilateral injury is present to extremities, the potential surgical extremity is to be compared against normal expected values of a sample population of similar age and gender, and evidence of remaining tendon and musculotendinous units that could be surgically repaired with sutures. - Injuries may encompass a single muscle belly or compartment. Whether an area is expected to be repaired by sutures will be determined from imaging studies and physical examination. - Have suffered traumatic injury within the last 18 months to the upper and/or lower extremity; Target of 18 months or less but subject's may be enrolled with injury outside this range if the principal investigator determines that there is viable muscle in the injured compartment determined by clinical exam and imaging studies. - Eligible for study procedures 3 months post injury with stability determined by the Principal Investigator and/ or MD Co-Investigator - Willing and able to comply with follow up examinations, radiographic studies, physical therapy, muscle biopsy and laboratory tests. Exclusion Criteria: - Patients with the following characteristics will be excluded from participating in the study: - Inability to provide informed consent - Poor nutrition (demonstrated by abnormal lab range for serum Albumin and Pre-Albumin values) - Chronic disease such as congestive heart failure, liver disease, renal disease, or diabetes - Active and unstable disease state or infection anywhere in the body per MD's evaluation and determination (demonstrated by stated or medical record history and abnormal lab range for CBC with Differential and Platelet, and chemistry panel values) - Known coagulopathy (demonstrated by stated or medical record history of diagnosis) - Pregnancy (demonstrated by a positive result of a urine pregnancy test) - Diagnosis of cancer within last 12 months and /or actively receiving chemotherapy or radiation treatment - Axis I diagnosis DSM-IV (e.g., Schizophrenia, Bipolar Disorder). Subjects who are found to be stable on medication and receive psychiatric clearance could be eligible for study participation per the Physician's discretion - Subjects with complete muscle/tendon gaps greater than 5 cm that are obvious on imaging studies and are unlikely to be reasonably repaired with sutures and reinforcement, and will be excluded. |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | University of Pittsburgh | Pittsburgh | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
University of Pittsburgh | United States Naval Medical Center, Portsmouth, United States Naval Medical Center, San Diego |
United States,
Beattie AJ, Gilbert TW, Guyot JP, Yates AJ, Badylak SF. Chemoattraction of progenitor cells by remodeling extracellular matrix scaffolds. Tissue Eng Part A. 2009 May;15(5):1119-25. doi: 10.1089/ten.tea.2008.0162. — View Citation
Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, Norotte C, Teng PN, Traas J, Schugar R, Deasy BM, Badylak S, Buhring HJ, Giacobino JP, Lazzari L, Huard J, Péault B. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008 Sep 11;3(3):301-13. doi: 10.1016/j.stem.2008.07.003. — View Citation
Holcomb JB, Stansbury LG, Champion HR, Wade C, Bellamy RF. Understanding combat casualty care statistics. J Trauma. 2006 Feb;60(2):397-401. — View Citation
Hostetler SG, Schwartz L, Shields BJ, Xiang H, Smith GA. Characteristics of pediatric traumatic amputations treated in hospital emergency departments: United States, 1990-2002. Pediatrics. 2005 Nov;116(5):e667-74. — View Citation
Mazurek MT, Ficke JR. The scope of wounds encountered in casualties from the global war on terrorism: from the battlefield to the tertiary treatment facility. J Am Acad Orthop Surg. 2006;14(10 Spec No.):S18-23. Review. — View Citation
Noe A. Extremity injury in war: a brief history. J Am Acad Orthop Surg. 2006;14(10 Spec No.):S1-6. — View Citation
Reing JE, Zhang L, Myers-Irvin J, Cordero KE, Freytes DO, Heber-Katz E, Bedelbaeva K, McIntosh D, Dewilde A, Braunhut SJ, Badylak SF. Degradation products of extracellular matrix affect cell migration and proliferation. Tissue Eng Part A. 2009 Mar;15(3):605-14. doi: 10.1089/ten.tea.2007.0425. — View Citation
Valentin JE, Badylak JS, McCabe GP, Badylak SF. Extracellular matrix bioscaffolds for orthopaedic applications. A comparative histologic study. J Bone Joint Surg Am. 2006 Dec;88(12):2673-86. — View Citation
Zantop T, Gilbert TW, Yoder MC, Badylak SF. Extracellular matrix scaffolds are repopulated by bone marrow-derived cells in a mouse model of achilles tendon reconstruction. J Orthop Res. 2006 Jun;24(6):1299-309. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mechanical strength and function | The primary objective of the study is to assess mechanical strength and function of surgical extremity in patients undergoing Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) with the use of biologic scaffolds for the restoration of both mechanical strength and function in these patients. Physical therapy evaluations of strength and active/passive range of motion and self-reported measures of ability to perform activities of daily living. | Approximately 6 months post-operative | Yes |
Secondary | Pathology Evaluation | The secondary objective is to examine the cellular properties of the biopsy tissue material from the Extracellular Matrix surgical site for reabsorption and replacement by the subjects own soft tissue with pathological findings to be correlated with clinical outcomes. | Approximately 6 months post-operative | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05988476 -
Investıgatıon of The Effıciency of Pulsed Electromagnetıc Field Therapy and Stretching Exercises
|
N/A | |
Active, not recruiting |
NCT05344183 -
Immediate and Short-term Effects of Low-level Laser
|
N/A | |
Completed |
NCT05367648 -
Effects of Protein Hydrolysate Supplement on Systemic Muscle Function Markers Following Resistance Type Exercise in Male Subjects
|
N/A | |
Not yet recruiting |
NCT05279196 -
Biological Variables Associated With the Response to Intensive Training in Athletes
|
N/A | |
Completed |
NCT05254470 -
Real-World Experience of Patients Treated for Musculoskeletal Injuries With SAM in Routine Care
|
||
Completed |
NCT03676205 -
Platelet-Rich Plasma in Acute Muscle Injuries
|
Phase 2 | |
Completed |
NCT05827484 -
The Effect of Combined Use of Anti-fibrotic Agent With Platelet Rich Plasma on Skeletal Muscle Healing After Acute Injuries
|
Phase 4 | |
Completed |
NCT04177537 -
Real-World Experience of Athletes Treated With SAM
|
||
Completed |
NCT01525667 -
Safety and Efficacy of IM Injections of PLX-PAD for the Regeneration of Injured Gluteal Musculature After Total Hip Arthroplasty
|
Phase 1/Phase 2 | |
Completed |
NCT04535635 -
Effects of ART® on Lower Limb Myofascial Pain and Function
|
N/A | |
Completed |
NCT04874662 -
Nicotinamide (NAM) and Pyridoxine (Vitamin B6) on Muscle Regeneration ("Satellite-01 Study").
|
N/A | |
Completed |
NCT04742244 -
Lemon Verbena Extract Oxidative Stress and Muscle Damage
|
N/A | |
Active, not recruiting |
NCT04483986 -
Does Rectus Re-approximation Cause Adhesion After Cesarean Section?
|
N/A | |
Recruiting |
NCT06205537 -
Muscle Health and Recovery in Older Adults
|
N/A | |
Recruiting |
NCT05216666 -
The Role of Surgical Approach on Residual Limping After Total Hip Arthroplasty
|
N/A | |
Completed |
NCT02077413 -
Muscle Injury Prevention & Rehabilitation in Military Personnel
|
N/A | |
Terminated |
NCT01751503 -
Extramembranous and Interosseous Technique of Tibialis Posterior Tendon Transfer
|
N/A | |
Completed |
NCT04586712 -
Efficacy of a Controlled Short-term Trial of Cannabidiol (CBD) Ingestion on Reducing Symptomatic Response and Facilitating Recovery After Induced Muscle Injury
|
Phase 2 | |
Completed |
NCT04123782 -
Focused Shockwave Treatment in the Recovery Process of Acute Muscle Injuries in Soccer Players
|
N/A | |
Not yet recruiting |
NCT01097798 -
To Evaluate the Efficacy and Safety Aliviador Compared to Gelol in Patients With Contusions, Sprains, Trauma and Muscle Injury.
|
Phase 3 |